Delivery Order SPE2DB22D2206-SPE2DB24FHW91

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $95K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,521.95. The contract is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025, serving as...
The U.S. government awarded a Delivery Order contract worth $1,669.95 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, with a period of performance through May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the...
The U.S. government awarded a Delivery Order contract worth $1,933.32 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, which has a completion date of July 12, 2024, is for the provision of a variety of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,929.80 with a completion date of June 10, 2024. The contract is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, worth $1,623.54, is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of medical commodities to DLA facilities...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,438.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. This order is part of a larger single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,129.44 to provide pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. The order is placed under a larger single-award Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), is a $13,291.92 Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of pharmaceutical products and medical supplies, with an ultimate completion date of July 9, 2024. Amerisourcebergen, a leading pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $849,396.33 with a completion date of May 10, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). It is a Firm Fixed Price contract for the provision of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Armed Forces worldwide. Amerisourcebergen, one of the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $18,431.36 with a completion date of May 24, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to provide a wide range of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits....
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHW91
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of pharmaceutical products, including the medication Sorafenib 200 mg tablet, to the Defense Logistics Agency (DLA). The $94,816.33 delivery order contract has a firm fixed price pricing type and an ultimate completion date of June 25, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract does not have a set-aside designation.

Generated 9/23/24, 9:55 AM